Pharvaris N.V. Files January 2025 6-K Report

Ticker: PHVS · Form: 6-K · Filed: Jan 13, 2025 · CIK: 1830487

Pharvaris N.V. 6-K Filing Summary
FieldDetail
CompanyPharvaris N.V. (PHVS)
Form Type6-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 6-K, regulatory-update

Related Tickers: PHVS

TL;DR

Pharvaris N.V. (PHVS) filed its monthly 6-K report on Jan 13, 2025, confirming ongoing compliance.

AI Summary

Pharvaris N.V. filed a Form 6-K on January 13, 2025, reporting for the month of January 2025. The company, incorporated in P7 and headquartered in Leiden, The Netherlands, is in the Pharmaceutical Preparations industry. This filing indicates they are submitting their report under the 1934 Act and will file annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for investors and regulatory bodies regarding Pharvaris N.V.'s ongoing reporting obligations.

Risk Assessment

Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.

Key Numbers

  • 001-40010 — SEC File Number (Identifies the company's filing history with the SEC)

Key Players & Entities

  • Pharvaris N.V. (company) — Filer of the 6-K report
  • 0000950170-25-004542 (filing_id) — Accession number for the filing
  • 20250113 (date) — Filing date
  • Leiden, The Netherlands (location) — Company headquarters
  • 2834 (sic_code) — Standard Industrial Classification for Pharmaceutical Preparations

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer has made or is about to make or has had made or is about to have made public in the foreign country.

What period does this specific 6-K filing cover?

This Form 6-K report is for the month of January 2025.

What is Pharvaris N.V.'s primary business sector?

Pharvaris N.V. is in the Pharmaceutical Preparations sector, indicated by SIC code 2834.

Does Pharvaris N.V. file annual reports under Form 20-F or 40-F?

Pharvaris N.V. indicates it files annual reports under cover of Form 20-F.

Where is Pharvaris N.V. headquartered?

Pharvaris N.V. is headquartered at Emmy Noetherweg 2, 2333 BK Leiden, The Netherlands.

Filing Stats: 496 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-13 06:51:02

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PHARVARIS N.V. Date: January 13, 2025 By: /s/ Berndt Modig Name: Berndt Modig Title: Chief Executive Officer EXHIBIT INDEX Exhibit No. Description 99.1 Press release, dated January 13, 2025. 99.2 Investor Presentation, dated January 13, 2025.

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.